Takayasu Kurata
- Oncology top 0.5%
- Lung Cancer Research Studies 48
- Colorectal Cancer Treatments and Studies 42
- Cancer Immunotherapy and Biomarkers 40
- Cancer Treatment and Pharmacology 19
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 108
- Lung Cancer Diagnosis and Treatment 30
- Virology top 2%
- Infectious Diseases top 2%
- Immunology and Allergy top 2%
-
- Herpesvirus Infections and Treatments 23
- Cytomegalovirus and herpesvirus research 16
- Co-authors
- Shinya TanakaMasahiro FukuokaKenji TamuraKazuhiko NakagawaAsato KojimaMichiyuki MatsudaTetsutaro SataMasaaki Shibuya
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Takayasu Kurata
246 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 3.2k
- Pulmonary and Respiratory Medicine 3.0k
- Virology 283
- Infectious Diseases 941
- Immunology and Allergy 286
Countries citing papers authored by Takayasu Kurata
This map shows the geographic impact of Takayasu Kurata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayasu Kurata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayasu Kurata more than expected).
Fields of papers citing papers by Takayasu Kurata
This network shows the impact of papers produced by Takayasu Kurata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayasu Kurata. The network helps show where Takayasu Kurata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takayasu Kurata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 19 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 40 | |
| 14 | 2020 | 4 | |
| 15 | Safety/Tolerability of 1L Pembrolizumab+Chemotherapy in Japanese Patients with Metastatic Nonsquamous NSCLC: KEYNOTE-189 | 2019 | 0 |
| 16 | 2018 | 8 | |
| 17 | 2014 | 37 | |
| 18 | 2011 | 45 | |
| 19 | Survivin inhibition by si-RNA induces apoptosis and increases sensitivity to adriamycin in human lung cancer cells with p53 mutation | 2004 | 12 |
| 20 | [Aggressive diffuse lymphoma with malignant pleural effusion expressing c-erbB-2 (neu) oncogene products]. | 1993 | 1 |
About Takayasu Kurata
Takayasu Kurata is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Virology, having authored 260 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (108 papers), Lung Cancer Research Studies (48 papers), Colorectal Cancer Treatments and Studies (42 papers), Cancer Immunotherapy and Biomarkers (40 papers), Lung Cancer Diagnosis and Treatment (30 papers), Herpesvirus Infections and Treatments (23 papers), Cancer Treatment and Pharmacology (19 papers) and Cytomegalovirus and herpesvirus research (16 papers). The work is most often cited by research in Oncology (3.2k citations), Pulmonary and Respiratory Medicine (3.0k citations) and Virology (283 citations). Takayasu Kurata has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shinya Tanaka, Masahiro Fukuoka, Kenji Tamura, Kazuhiko Nakagawa, Asato Kojima, Michiyuki Matsuda, Tetsutaro Sata, Masaaki Shibuya, Isamu Okamoto and K Nagashima. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.